US companies producing drones and drones solutions such as Kratos Defense (KTOS.US) and AeroVironment (AVIV.US) gain more than 10% today amid US defence secretary Hegseth signalling a new Pentagon strategy focused on drones military potential. The US Department of Defense announced a directive to "unleash U.S. military drone dominance yesterday. The U.S. Department of Defense (DoD) is scrapping old restrictions and fast-tracking domestic drone adoption in a bold move to boost battlefield readiness and technological dominance.
-
The DoD rescinds 2021–2022 policies that blocked military units from buying drones with Chinese-made components.
-
Troops can now buy, test, and train with compliant small unmanned aerial systems (UAS) without bureaucratic delays.
-
Hundreds of American-made drone products are now approved for military use, aiming to rival adversaries who mass-produce low-cost drones.
-
The DoD encourages private investment to fuel domestic drone innovation and AI-driven combat systems.
-
The roster of DoD-approved drones and software—Blue UAS—is growing rapidly.
-
Drone combat will become part of official military training in 2025, including simulated drone-on-drone warfare.
AeroVironment and Kratos Defense stock charts
Source: xStation5
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app
Source: xStation5
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
